Market News
Stay updated with the latest market trends, earnings, and economic indicators.
eClerx Services Ltd leads gainers in 'A' group
Tanla Platforms Ltd, Coforge Ltd, Supriya Lifescience Ltd and Angel One Ltd are among the other gainers in the BSE's 'A' group today, 19 May 2026.
Mankind Pharma Ltd rises for third straight session
Mankind Pharma Ltd is quoting at Rs 2511.4, up 2% on the day as on 12:49 IST on the NSE. The stock is down 2.38% in last one year as compared to a 4.94% slide in NIFTY and a 13.93% slide in the Nifty Pharma index.
Zydus Lifesciences Ltd soars 2.1%
Zydus Lifesciences Ltd is quoting at Rs 1012.55, up 2.1% on the day as on 12:49 IST on the NSE. The stock is up 12.17% in last one year as compared to a 4.94% drop in NIFTY and a 13.93% drop in the Nifty Pharma index.
Biocon Ltd spurts 2.76%, rises for fifth straight session
Biocon Ltd is quoting at Rs 430.55, up 2.76% on the day as on 12:44 IST on the NSE. The stock is up 26.86% in last one year as compared to a 5.01% slide in NIFTY and a 13.99% slide in the Nifty Pharma.
Aurobindo Pharma Ltd soars 1.15%
Aurobindo Pharma Ltd is quoting at Rs 1514.7, up 1.15% on the day as on 12:49 IST on the NSE. The stock is up 24.47% in last one year as compared to a 5.39% drop in NIFTY and a 13.06% drop in the Nifty Pharma index.
Siemens eyes exit from cancer care chain American Oncology Institute
Siemens Healthineers is exiting its Indian cancer care chain, American Oncology Institute. The deal is valued between ₹1,500-2,000 crore. Private equity funds and Healthcare Global Enterprises are potential bidders. AOI operates 16 hospitals in India and one in Sri Lanka. This move aligns with Siemens Healthineers' broader strategic reviews. The Indian cancer care market is experiencing significant growth and investment.
Ajanta Pharma Ltd spurts 1.08%, rises for third straight session
Ajanta Pharma Ltd is quoting at Rs 3125, up 1.08% on the day as on 12:49 IST on the NSE. The stock is up 20.83% in last one year as compared to a 4.86% gain in NIFTY and a 11.37% gain in the Nifty Pharma index.
Biocon Ltd spurts 3.7%, gains for third straight session
Biocon Ltd is quoting at Rs 417.35, up 3.7% on the day as on 12:49 IST on the NSE. The stock is up 23.4% in last one year as compared to a 4.86% fall in NIFTY and a 11.37% fall in the Nifty Pharma index.

Kotak AMC’s Shibani Sircar Kurian bets on financials and healthcare; cautious on IT
Shibani Sircar Kurian, Head -Equity Research and Fund Manager at Kotak Mahindra AMC, which manages assets worth nearly $4.79 billion, said the ongoing Middle East conflict remains the biggest concern for Indian markets due to its potential impact on oil prices, growth and earnings. She said Kotak AMC remains selective, favouring financials, healthcare and parts of industrials, while staying cautious on smallcaps and Indian IT amid AI-led disruption. Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.
Unique Picks: 6 stocks held by only one MF scheme in April, falling up to 40% in CY26
An analysis of mutual fund portfolios revealed 29 stocks held exclusively by single schemes, with most underperforming in CY26. However, Satin Creditcare Network, Rossell Techsys, and Amanta Healthcare bucked the trend, delivering strong returns. Brooks Laboratories and EFC (I) were among those experiencing significant declines.
Glenmark Pharmaceuticals Ltd slips for fifth straight session
Glenmark Pharmaceuticals Ltd is quoting at Rs 2289.1, down 2.48% on the day as on 13:19 IST on the NSE. The stock jumped 61.5% in last one year as compared to a 4.21% slide in NIFTY and a 12.6% spurt in the Nifty Pharma index.
Laurus Labs Ltd spurts 1.07%, rises for fifth straight session
Laurus Labs Ltd is quoting at Rs 1280.4, up 1.07% on the day as on 12:44 IST on the NSE. The stock is up 115.1% in last one year as compared to a 4.28% drop in NIFTY and a 12.36% drop in the Nifty Pharma.